Building methodology for discovering and developing Chinese medicine based on network biology

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 2, 2011, Pages 228-231

  Wang, Yi ^a   Gao, Xiumei ^b   Zhang, Boli ^b   Cheng, Yiyu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Multi target drug design; Network biology; Network pharmacology; Network pharmacology of Chinese medicine

Indexed keywords

ARTICLE; CHINESE MEDICINE; MEDICAL INFORMATION SYSTEM; MEDICAL TECHNOLOGY; METHODOLOGY; NETWORK BIOLOGY; ANIMAL; BIOLOGY; DRUG THERAPY; HUMAN;

HERBACEOUS AGENT;

ANIMALS; BIOLOGY; DRUG THERAPY; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL;

EID: 79955962303     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110228     Document Type: Article

References (26)

1. Janssens A C J W, Khoury M J. Predictive value of testing for multiple genetic variants in multifactorial diseases: implications for the discourse on ethical, legal and social issues[J]. Ital J Pub Health, 2006, 3(3/4):35.
2. Wray N R, Goddard M E, Visscher P M. Prediction of individual genetic risk of complex disease[J]. Curr Opin Genet Dev, 2008, 18(3):257.
3. Frantz S. Drug discovery: playing dirty[J]. Nature, 2005, 437(7061):942.
4. Zimmermann G R, Lehar J, Keith C T. Multi-target therapeutics: when the whole is greater than the sum of the parts[J]. Drug Discov Today, 2007, 12(1/2):34.
5. Sams-Dodd F. Target-based drug discovery: is something wrong [J]. Drug Discov Today, 2005, 10(2):139.
6. Barabasi A L, Oltvai Z N. Network biology: understanding the cell's functional organization[J]. Nat Rev Genet, 2004, 5(2):101.
7. Hopkins A L. Network pharmacology: the next paradigm in drug discovery[J]. Nat Chem Biol, 2008, 4(11):682.
8. Hopkins A L. Network pharmacology[J]. Nat Biotechnol, 2007, 25(10):1110.
9. Ergun A, Lawrence C A, Kohanski M A, et al. A network biology approach to prostate cancer[J]. Mol Syst Biol, 2007, 3:82.
10. Lim J, Hao T, Shaw C, et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration[J]. Cell, 2006, 125(4):801.
11. Maáyan A, Jenkins S L, Goldfarb J, et al. Network analysis of FDA approved drugs and their targets [J]. Mt Sinai J Med, 2007, 74(1):27.
12. Xie L, Li J, Xie L, et al. Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors[J]. PLoS Comput Biol, 2009, 5(5):e1000387.
13. Keiser M J, Setola V, Irwin J J, et al. Predicting new molecular targets for known drugs[J]. Nature, 2009, 462(7270):175.
14. Jia J, Zhu F, Ma X, et al. Mechanisms of drug combinations: interaction and network perspectives[J]. Nat Rev Drug Discov, 2009, 8(2):111.
15. Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands[J]. Drug Discov Today, 2004, 9(15):641.
16. Yildirim M A, Goh K-I, Cusick M E, et al. Drug-target network [J]. Nat Bioctchn, 2007, 25(10):1119.
17. Campillos M, Kuhn M, Gavin A C, et al. Drug target identification using side-effect similarity[J]. Science, 2008, 321(5886):263.
18. Keiser M J, Roth B L, Armbruster B N, et al. Relating protein pharmacology by ligand chemistry[J]. Nat Biotechnol, 2007, 25(2):197.
19. Hwang W C, Zhang A, Ramanathan M. Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery[J]. Clin Pharmacol Ther, 2008, 84(5):563.
20. Oltvai Z N, Barabasi A L. Systems biology. Life's complexity pyramid[J]. Science, 2002, 298(5594):763.
21. Goh K I, Cusick M E, Valle D, et al. The human disease network[J]. Proc Natl Acad Sci USA, 2007, 104(21):8685.
22. Keith C T, Borisy A A, Stockwell B R. Multicomponent therapeutics for networked systems[J]. Nat Rev Drug Discov, 2005, 4(1):71.
23. Borisy A A, Elliott P J, Hurst N W, et al. Systematic discovery of multicomponent therapeutics [J]. Proc Natl Acad Sci USA, 2003, 100(13):7977.
24. Toda N, Tago K, Marumoto S, et al. A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease[J]. Bioorg Med Chem, 2003, 11(20):4389.
25. Wang Y, Yu L, Zhang L, et al. A novel methodology for multicomponent drug design and its application in optimizing the combination of active components from chinese medicinal formula shenmai[J]. Chem Biol Drug Des, 2010, 75(3):318.
26. Wang L, Zhou G B, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia [J]. Proc Natl Acad Sci USA, 2008, 105(12):4826.